STAA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
STAAR Surgical Co (STAA) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, and the options data reflects negative sentiment. Despite a slight revenue growth in the latest quarter, the company's net income and EPS have declined. Analysts have lowered price targets and expressed concerns about the company's recovery in the China market. Without any strong positive catalysts or trading signals, holding off on buying is recommended for now.
The technical indicators are bearish. The MACD is negative and expanding downward, the RSI is at 15.122 indicating an oversold condition, and the moving averages show a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 16.678) with resistance at R1: 18.787.
The company's gross margin increased to 82.21%, up 6.34% YoY, indicating operational efficiency. The stock is oversold as per RSI, which could attract bargain hunters.
Analysts have lowered price targets and expressed concerns about the company's recovery in the China market. Net income and EPS have declined YoY. Options data reflects bearish sentiment, and technical indicators are negative.
In Q3 2025, revenue increased by 6.93% YoY to $94.73M. However, net income dropped by 10.98% YoY to $8.88M, and EPS fell by 10.00% YoY to $0.18. Gross margin improved to 82.21%, up 6.34% YoY.
Analysts have a neutral to hold stance on the stock. Stifel lowered the price target to $19, Wedbush initiated coverage with a $26 price target but highlighted risks in the China market, and Canaccord reduced the price target to $22 after the Alcon deal rejection.
